Lv3
280 积分 2023-09-22 加入
Discovery of a Highly Potent, N-terminal Domain-targeting degrader of AR-FL/AR-V7 for the treatment of Prostate Cancer
1天前
已完结
An Update on JAK Inhibitors
12天前
已完结
Gut microbes and skin disease, gut-brain-skin axis: A review
15天前
已完结
Phthalimide conjugations for the degradation of oncogenic PI3K
23天前
已完结
PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer
23天前
已完结
Design, synthesis and activity study of a novel PI3K degradation by hijacking VHL E3 ubiquitin ligase
23天前
已完结
Discovery of the First Clinical Protein Degrader for the Treatment of Autoimmune Indications: Orally Bioavailable and Selective IRAK4 Degrader KT-474
1个月前
已完结
HSP90 Inhibition Has Potent Activity Against T-Cell Acute Lymphoblastic Leukemia (T-ALL) Through Degradation Of TYK2 Kinase
1个月前
已关闭
Novel TYK2 Inhibitors with an N-(Methyl-d3)pyridazine-3-carboxamide Skeleton for the Treatment of Autoimmune Diseases
2个月前
已完结
Between Theory and Practice: Computational/Experimental Integrated Approaches to Understand the Solubility and Lipophilicity of PROTACs
2个月前
已完结
皖公网安备34019202002308
